Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

EXCEL PHARMA : revenue, balance sheet and financial ratios

EXCEL PHARMA is a French company founded 14 years ago, specialized in the sector Conseil pour les affaires et autres conseils de gestion. Based in CROSNE (91560), this company of category PME shows in 2018 a net income positive of 113 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - EXCEL PHARMA (SIREN 534643499)
Indicator 2018 2017
Revenue N/C N/C
Net income 112 712 € 84 454 €
EBITDA N/C N/C
Net margin N/C N/C

Revenue and income statement

In 2018, EXCEL PHARMA generates positive net income of 113 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2018: 84 k€ -> 113 k€.

Net income (2018) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

112 712 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 39%. The balance between equity and debt is satisfactory.

Debt ratio (2018) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.0%

Financial autonomy (2018) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

38.561%

Asset age ratio (2018) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

52.6%

Solvency indicators evolution
EXCEL PHARMA

Sector positioning

Debt ratio
0.0 2018
2017
2018
Q1: 0.0
Med: 4.48
Q3: 43.96
Excellent

In 2018, the debt ratio of EXCEL PHARMA (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
38.56% 2018
2017
2018
Q1: 5.8%
Med: 39.4%
Q3: 72.72%
Average -26 pts over 2 years

In 2018, the financial autonomy of EXCEL PHARMA (38.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 157.67. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2018) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

157.669

Liquidity indicators evolution
EXCEL PHARMA

Sector positioning

Liquidity ratio
157.67 2018
2017
2018
Q1: 134.77
Med: 263.86
Q3: 637.17
Average -28 pts over 2 years

In 2018, the liquidity ratio of EXCEL PHARMA (157.67) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Positioning of EXCEL PHARMA in its sector

Comparison with sector Conseil pour les affaires et autres conseils de gestion

Valuation estimate

Based on 69 transactions of similar company sales in 2018, the value of EXCEL PHARMA is estimated at 435 595 € (range 181 967€ - 1 138 202€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2018
69 tx
181k€ 435k€ 1138k€
435 595 € Range: 181 967€ - 1 138 202€
NAF 5 année 2018

Valuation method used

Net Income Multiple
112 712 € × 3.9x = 435 596 €
Range: 181 967€ - 1 138 202€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 69 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Conseil pour les affaires et autres conseils de gestion)

Compare EXCEL PHARMA with other companies in the same sector:

Voir toutes les statistiques du secteur Conseil pour les affaires et autres conseils de gestion

Frequently asked questions about EXCEL PHARMA

What is the revenue of EXCEL PHARMA ?

The revenue of EXCEL PHARMA is not publicly disclosed (confidential accounts filed with INPI).

Is EXCEL PHARMA profitable?

Yes, EXCEL PHARMA generated a net profit of 113 k€ in 2018.

Where is the headquarters of EXCEL PHARMA ?

The headquarters of EXCEL PHARMA is located in CROSNE (91560), in the department Essonne.

Where to find the tax return of EXCEL PHARMA ?

The tax return of EXCEL PHARMA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does EXCEL PHARMA operate?

EXCEL PHARMA operates in the sector Conseil pour les affaires et autres conseils de gestion (NAF code 70.22Z). See the 'Sector positioning' section above to compare the company with its competitors.